Tamro Sweden

Total pharmaceutical sales for the period February–July 2007 were EUR 1,473 million in PPP, which represents a growth of 7 percent (CER) compared to last year. During the first six months of this reporting period the net sales of Tamro Sweden increased to EUR 853 (824) million. Tamro’s average market share for February–July was 53%.

During this reporting period Tamro Sweden lost the contract with one of its main principals, but it was replaced by another distribution agreement of nearly the same value.

Mr. Mats Johnson was employed as  the new Logistic Director of Tamro Sweden at the beginning of this reporting period.

Tamro Sweden’s share of the Group’s net sales was 31%, and the company employed an average of 445 (446) people.

The enquiry concerning the liberalisation of the Swedish pharmacy markets is still ongoing and the proposals are promised to be ready by the end of this year. The authorities in Sweden have also published an official proposal for deregulating the nicotine treatment products.